JP2007176835A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007176835A5 JP2007176835A5 JP2005375332A JP2005375332A JP2007176835A5 JP 2007176835 A5 JP2007176835 A5 JP 2007176835A5 JP 2005375332 A JP2005375332 A JP 2005375332A JP 2005375332 A JP2005375332 A JP 2005375332A JP 2007176835 A5 JP2007176835 A5 JP 2007176835A5
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- external preparation
- purified product
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003491 Skin Anatomy 0.000 claims description 54
- 238000002360 preparation method Methods 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 44
- 210000002510 Keratinocytes Anatomy 0.000 claims description 28
- 239000012264 purified product Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 241000218657 Picea Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 11
- 239000002798 polar solvent Substances 0.000 claims description 11
- 230000004625 regulation of water loss via skin Effects 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 7
- 240000003472 Citrus aurantium Species 0.000 claims description 7
- 229940025878 Hesperidin Drugs 0.000 claims description 7
- QUQPHWDTPGMPEX-YEDPJISVSA-N Hesperidin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C[C@@H](c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 QUQPHWDTPGMPEX-YEDPJISVSA-N 0.000 claims description 7
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 7
- 230000035699 permeability Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 4
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 4
- 238000007792 addition Methods 0.000 claims description 4
- 241001672694 Citrus reticulata Species 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000000622 liquid--liquid extraction Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims 1
- -1 polyethylene terephthalate Polymers 0.000 description 35
- 239000002609 media Substances 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 5
- 229910001424 calcium ion Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 4
- 229940039717 Lanolin Drugs 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 210000004027 cells Anatomy 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960005069 Calcium Drugs 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 229960004063 Propylene glycol Drugs 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L Barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 2
- 235000016646 Citrus taiwanica Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L Dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- 229940009714 Erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- QUEDXNHFTDJVIY-WENCSYSZSA-N gamma-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@](CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-WENCSYSZSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-(4S)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- YPXOPAFVVHXQDP-ZZEZOPTASA-N (1Z)-1-[(2,4-dimethylphenyl)hydrazinylidene]naphthalen-2-one Chemical compound CC1=CC(C)=CC=C1N\N=C/1C2=CC=CC=C2C=CC\1=O YPXOPAFVVHXQDP-ZZEZOPTASA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- HYRUXGRHTJRKNG-SMBWEDIMSA-N (2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5R,6S)-6-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound O[C@@H]1[C@@H](O)[C@H](OC)O[C@H](CO)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](OC)[C@@H](CO)O2)O)[C@@H](CO)O1 HYRUXGRHTJRKNG-SMBWEDIMSA-N 0.000 description 1
- WKPUACLQLIIVJJ-RHKLHVFKSA-M (2S,3R,4R,5S,6R)-4-hydroxy-3-methoxy-6-[(2S,3R,4S,5S,6R)-6-methoxy-4-oxido-5-(sulfooxyamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxyoxane-2-carboxylate Chemical compound [O-][C@H]1[C@H](NOS(O)(=O)=O)[C@H](OC)O[C@@H](COS(O)(=O)=O)[C@@H]1O[C@H]1[C@@H](OS(O)(=O)=O)[C@H](O)[C@@H](OC)[C@@H](C([O-])=O)O1 WKPUACLQLIIVJJ-RHKLHVFKSA-M 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-M 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC([O-])=O XDOFQFKRPWOURC-UHFFFAOYSA-M 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N 2,2-dimethylpropane-1,3-diol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- NRANXTWANPHZAU-UHFFFAOYSA-N 2-(1H-quinolin-2-ylidene)indene-1,3-dione Chemical compound N1C2=CC=CC=C2C=CC1=C1C(=O)C2=CC=CC=C2C1=O NRANXTWANPHZAU-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N 2-Imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N 2-Pyrrolidone Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-hydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- BGBDMEPBLWJCHI-UHFFFAOYSA-N 5-methyl-2-[[4-(4-methyl-2-sulfoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S(O)(=O)=O BGBDMEPBLWJCHI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N Anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N Benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- GLQBXSIPUULYOG-UHFFFAOYSA-M Bismuth oxychloride Chemical compound Cl[Bi]=O GLQBXSIPUULYOG-UHFFFAOYSA-M 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Bute hydrocarbon Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- 229940073532 Candelilla Wax Drugs 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229940113118 Carrageenan Drugs 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N Chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- LBFUKZWYPLNNJC-UHFFFAOYSA-N Cobalt(II,III) oxide Chemical compound [Co]=O.O=[Co]O[Co]=O LBFUKZWYPLNNJC-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 240000000590 Cydonia oblonga Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229940105990 DIGLYCERIN Drugs 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N Dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- NOPFSRXAKWQILS-UHFFFAOYSA-N Docosanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229940096919 Glycogen Drugs 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N Hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N Hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N Keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 229960000448 Lactic acid Drugs 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N Mannan Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- TZIHFWKZFHZASV-UHFFFAOYSA-N Methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 229940117969 NEOPENTYL GLYCOL Drugs 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229940116985 POTASSIUM LAURYL SULFATE Drugs 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229940055726 Pantothenic Acid Drugs 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 240000003877 Perilla frutescens Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M Potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- MMXZSJMASHPLLR-UHFFFAOYSA-N Pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N Rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 229940010747 Sodium Hyaluronate Drugs 0.000 description 1
- 229940005581 Sodium Lactate Drugs 0.000 description 1
- 229940045870 Sodium Palmitate Drugs 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M Sodium laurate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 Sodium laurate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M Sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 229960005078 Sorbitan sesquioleate Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- YXHBBEQKMVAJOH-GLCFPVLVSA-K Tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 YXHBBEQKMVAJOH-GLCFPVLVSA-K 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N Tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N Undecylenic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N Vinyl fluoride Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 229940045997 Vitamin A Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- RMRCNWBMXRMIRW-WYVZQNDMSA-L Vitamin B12 Chemical compound N([C@@H]([C@@]1(C)[C@@](C)(CC(N)=O)[C@H](CCC(N)=O)\C(N1[Co+]C#N)=C(/C)\C1=N\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NCC(C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO RMRCNWBMXRMIRW-WYVZQNDMSA-L 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- NWGKJDSIEKMTRX-HSACVWGTSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-HSACVWGTSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001058 adult Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha Tocopherol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- JNIGYQOBELCEIZ-MAKDUZDQSA-L barium(2+);5-chloro-4-methyl-2-[(2Z)-2-(2-oxonaphthalen-1-ylidene)hydrazinyl]benzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N\N=C/2C3=CC=CC=C3C=CC\2=O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N\N=C/2C3=CC=CC=C3C=CC\2=O)=C1S([O-])(=O)=O JNIGYQOBELCEIZ-MAKDUZDQSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229930007075 carvone Natural products 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229950008690 docosanoic acid Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- CNNPNFVEEMWBBH-UHFFFAOYSA-N dodecyl(oxido)azanium Chemical compound CCCCCCCCCCCC[NH2]=O CNNPNFVEEMWBBH-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth media Substances 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910000460 iron oxide Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 239000011776 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910001929 titanium oxide Inorganic materials 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
Description
本発明は、皮膚外用剤とその製造方法に関し、詳しくは皮膚バリア機能を向上させる皮膚外用剤とその製造方法に関する。
The present invention relates to a method of manufacturing the skin Hadagaiyo agent, details and its manufacturing how skin external agent for improving skin barrier function.
本発明は、この様な状況下為されたものであり、皮膚そのもののバリア機能を向上させる手段を提供することを課題とした。
The present invention has been made under such circumstances, and an object of the present invention is to provide means for improving the barrier function of the skin itself.
この様な状況に鑑みて、本発明者らは、皮膚そのもののバリア機能を向上させる皮膚外用剤を簡便に得る手段を求めて鋭意研究努力を重ねた結果、表皮角化細胞をカルシウムイオンを0.1〜0.2mM含有する液体培地で0.1〜12μmの微細孔を有する支持体上にコンフルエントになるまで培養し、しかる後に、カルシウムイオンを1〜2mM含有する液体培地で培養することにより、皮膚バリア機能を簡便に評価できる表皮角化細胞層膜が得られること、またこの表皮角化細胞層膜に、ミカン科ミカン属ダイダイの果皮(トウヒ)を極性溶媒で抽出して得られた抽出物、もしくは該抽出物を更に分画、精製して得られた分画精製物を、前記表皮角化細胞層膜の存する液体培地中に含有せしめることにより、表皮角化細胞層膜のバリア機能が向上すること、更にこの抽出物を皮膚外用剤に含有せしめることにより、簡便に皮膚そのもののバリア機能を向上させる皮膚外用剤が得られることなどを見出し、本発明を完成させた。すなわち、本発明は、以下に示す通りである。
In view of such a situation, the present inventors have intensively studied for a means for easily obtaining an external preparation for skin that improves the barrier function of the skin itself. As a result, the epidermis keratinocytes have 0 calcium ions. By culturing on a support having 0.1 to 12 μm micropores in a liquid medium containing 1 to 0.2 mM until confluent, and then culturing in a liquid medium containing 1 to 2 mM calcium ions , and this epidermal keratinocytes layer membrane can be conveniently evaluated skin barrier function is obtained, also in the epidermal keratinocytes layer film, obtained by extracting citrus family citrus aurantium peels the (spruce) in a polar solvent extracts, or further fractionated the extracts, fractions purified product obtained by purifying, by incorporating in the liquid medium residing of the epidermal keratinocytes layer membranes, epidermal keratinocytes layer film barrier The ability is improved, and further by incorporating the extract to the skin external preparation, conveniently found such that the external skin preparation for improving the barrier function of the skin itself is obtained, to complete the present invention. That is, the present invention is as follows.
(1) ミカン科ミカン属ダイダイの果皮(トウヒ)を極性溶媒で抽出して得られた抽出物、もしくは該抽出物を分画、精製して得られた分画精製物を皮膚外用剤に含有させる皮膚外用剤の製造方法において、表皮角化細胞をカルシウムを0.1〜0.2mM含有する液体培地で0.1〜12μmの微細孔を有する支持体上でコンフルエントになるまで培養し、しかる後、カルシウムイオンを1〜2mM含有する液体培地で培養して得られる表皮角化細胞層膜を、前記抽出物又は分画精製物で処理した場合に、該表皮角化細胞層膜の物質透過性を抑制する作用を有することを確認し、該作用を有する抽出物又は分画精製物を皮膚外用剤に含有せしめることを特徴とする、皮膚外用剤の製造方法。
(2) 前記極性溶媒が含水エタノール又は含水1,3−ブタンジオールであることを特
徴とする、(1)に記載の皮膚外用剤の製造方法。
(3) 前記分画精製物が、前記抽出物から極性溶媒を除去し、しかる後に酢酸エチルと水を加え、液−液抽出し、酢酸エチル層を取り、該酢酸エチル層の溶媒を除去して得られたものであることを特徴とする、(1)又は(2)に記載の皮膚外用剤の製造方法。
(4) 前記表皮角化細胞がヒト由来のものであることを特徴とする、(1)〜(3)何れか1つに記載の皮膚外用剤の製造方法。
(5) 未処理の表皮角化細胞層膜に比して、TER(Transepithelial Electrical Resistance)値が10%以上増加する場合、前記皮膚外用剤が、前記表皮角化細胞層膜の物質透過性を抑制する作用を有するとすることを特徴とする、(1)〜(4)何れか1つに記載の皮膚外用剤の製造方法。
(6) 前記皮膚外用剤が、皮膚バリア機能改善用であることを特徴とする(1)〜(5)何れか1つに記載の皮膚外用剤の製造方法。
(7) ミカン科ミカン属ダイダイの果皮を極性溶媒で抽出して得られた抽出物、もしくは該抽出物を分画、精製して得られた分画精製物を、含有するヘスペリジンの量を指標として、皮膚バリア機能を向上させるのに充分な量で配合することを特徴とする、皮膚外用剤。
(8) 前記抽出物又は分画精製物中のヘスペリジン含有量が0.05〜0.1質量%となるように50%エタノール水溶液を添加して調整したものを0.01〜1質量%含有することを特徴とする、(7)に記載の皮膚外用剤。
(1) Contains an extract obtained by extracting the peel (spruce) of the mandarin orange mandarin genus with a polar solvent , or a fraction purified product obtained by fractionating and purifying the extract as a skin external preparation. In the method for producing an external preparation for skin , epidermal keratinocytes are cultured in a liquid medium containing 0.1 to 0.2 mM of calcium until it becomes confluent on a support having 0.1 to 12 μm micropores. after, when the epidermal keratinocytes layer film obtained by culturing in a liquid medium 1~2mM containing calcium ions, and treated with the extract or fraction purified product, material permeability of the epidermis keratinocyte layer film confirmed to have an effect of suppressing sex, it characterized by allowed to contain an extract or fractionated purified product having a the acting external preparation for skin, producing how the skin external preparation.
(2), wherein the polar solvent medium is a water-containing ethanol or water-containing 1,3-butanediol, prepared how the skin external preparation as described in (1).
(3) the fraction purified product is, the polar solvent is removed from the extract, whereafter ethyl acetate and water were added to the liquid - liquid extraction to take ethyl acetate layer, the solvent was removed in acetic acid ethyl layer characterized in that it was collected using, (1) or manufacture how the skin external preparation as described in (2).
(4), wherein the epidermal keratinocytes are of human origin, (1) - (3) producing how the skin external preparation according to any one.
(5) When the TER (Transepithelial Electrical Resistance) value is increased by 10% or more as compared with an untreated epidermal keratinocyte layer membrane, the external preparation for skin has a substance permeability of the epidermal keratinocyte layer membrane. The method for producing an external preparation for skin according to any one of (1) to (4), which has an inhibitory action.
(6) The method for producing an external preparation for skin according to any one of (1) to (5), wherein the external preparation for skin is used for improving a skin barrier function.
(7) The amount of hesperidin contained in the extract obtained by extracting the peel of the citrus fruit genus Daidai with a polar solvent, or the fraction purified product obtained by fractionating and purifying the extract as, wherein the blending in an amount sufficient to improve the skin barrier function, the skin external preparation.
(8) the extract or 0.01 to 1 mass what Hesuperiji emissions containing chromatic amount of fraction purified product in was adjusted by addition of 50% aqueous ethanol solution such that 0.05 to 0.1 mass% The skin external preparation as described in (7) characterized by containing%.
本発明の皮膚外用剤の製造方法は、ミカン科ミカン属ダイダイの果皮(トウヒ)を極性溶媒で抽出して得られた抽出物、もしくは該抽出物を更に分画、精製して得られた分画精製物を皮膚外用剤に含有させる皮膚外用剤の製造方法において、表皮角化細胞をカルシウムを0.1〜0.2mM含有する液体培地で0.1〜12μmの微細孔を有する支持体上でコンフルエントになるまで培養し、しかる後、カルシウムイオンを1〜2mM含有する液体培地で培養して得られる表皮角化細胞層膜を、前記抽出物又は分画精製物で処理した場合に、該表皮角化細胞層膜の物質透過性を抑制する作用を有することを確認し、該作用を有する該抽出物又は分画精製物を皮膚外用剤に含有せしめることを特徴とする。
Producing how the skin external preparation of the present invention was obtained Rutaceae Citrus aurantium peels the (spruce) extract obtained by extraction with a polar solvent, or further fractionated extract, purified In the method for producing a skin external preparation containing the fractionated purified product in the skin external preparation, a support having 0.1 to 12 μm fine pores in a liquid medium containing 0.1 to 0.2 mM calcium as epidermal keratinocytes were cultured to confluence on, thereafter, when the epidermal keratinocytes layer film obtained by culturing calcium ions in a liquid medium containing 1-2 mM, was treated with the extract or fraction purified product, It is confirmed that the substance has an action of suppressing substance permeability of the epidermal keratinocyte layer membrane, and the extract or fraction purified product having the action is contained in an external preparation for skin.
前記、ミカン科ミカン属ダイダイの果皮(トウヒ)の抽出物の製造に用いる溶媒としては極性溶媒が挙げられ、水、エタノールやイソプロパノール等のアルコール類、アセトン、メチルエチルケトン等のケトン類、アセトニトリルなどのニトリル類、ジエチルエーテルやテトラヒドロフラン等のエーテル類、酢酸エチルや蟻酸メチル等のエステル類、1,3−ブタンジオール、プロピレングリコール等の多価アルコール類が好ましく例示できる。これらは単独でも複数を混合して用いても良い。抽出に際しては、植物体乃至はその加工物1質量部に対して、1〜10質量部の溶媒を加え、室温であれば数日間、沸点付近の温度であれば数時間、所望により攪拌を加え、浸漬すればよい。浸漬後、所望により濾過などで不溶物を除去し、必要に応じて溶媒除去などを行い用いることができる。更に、こ
れらを液−液抽出、イオン交換樹脂やシリカゲルを担体としたクロマトグラフィーなどを用いて分画精製物とすることもできる。
Wherein, as the solvent medium used in the preparation of the extract of citrus family Citrus aurantium peel (spruce) include polar Solvent, water, alcohols such as ethanol and isopropanol, ketones such as acetone and methyl ethyl ketone, acetonitrile, etc. Preferred examples include nitriles of the above, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and methyl formate, and polyhydric alcohols such as 1,3-butanediol and propylene glycol. These may be used alone or in combination. At the time of extraction, the plant body or its workpiece 1 part by mass, addition of Solvent 1 to 10 parts by weight, for several days if room temperature for several hours if the temperature around the boiling point, stirring if desired In addition, it may be immersed. After soaking, the insoluble matter can be removed by filtration or the like, if necessary, and the solvent can be removed if necessary. Further, these liquid - liquid extraction can also be a fractionated purified product by using a chromatography using ion exchange resin or silica gel as carrier.
かくして得られた抽出物又は分画精製物は表皮角化細胞をカルシウムを0.1〜0.2mM含有する液体培地で0.1〜12μmの微細孔を有する支持体上でコンフルエントになるまで培養し、しかる後、カルシウムイオンを1〜2mM含有する液体培地で培養し、さらに前記抽出物又は分画精製物を含有する、或いは含有しない液体培地で培養して得られる表皮角化細胞層膜を用い、それぞれの細胞層膜で隔てられた二室のチャンバーの一室に指標物質を充填し、被検物質の他室への移動の程度が、前記抽出物又は分画精製物の有無において、前記抽出物又は分画精製物を含有する培養液で培養した細胞層膜における物質の透過性の抑制作用を有する分画を求め、かかる作用が皮膚外用剤への配合において十分に効果を奏するとは、この作用が10%以上の抑制作用を示すことであり、かかる濃度を決定し、皮膚外用剤への配合量が決定される。0.1〜12μmの微細孔を有する支持体としては、コーニング社やミリポア社より、ポリエチレンテレフタレート製、ポリカーボネート製、コラーゲン処理ポリテトタフルオロエチレン製の膜が市販されているので、これらを購入して使用することができ、好ましい。これらを用いた測定方法に関しては以下に一例を示す。
The extract or fraction-purified product thus obtained is cultured until the epidermal keratinocytes are confluent on a support having 0.1 to 12 μm micropores in a liquid medium containing 0.1 to 0.2 mM calcium. Then, an epidermal keratinocyte layer membrane obtained by culturing in a liquid medium containing 1 to 2 mM of calcium ions and further culturing in a liquid medium containing or not containing the extract or fractionated purified product. Used, filling one chamber of two chambers separated by each cell layer membrane with an indicator substance, the degree of movement of the test substance to the other chamber in the presence or absence of the extract or fraction purified product , Obtaining a fraction having an action of suppressing the permeability of a substance in a cell layer membrane cultured in a culture solution containing the extract or the fraction-purified product , and such action is sufficiently effective in blending into an external preparation for skin This work There is to show an inhibitory effect of 10% or more, and determine such concentrations, the amount of the skin external preparation is determined. The support having fine pores of 0.1~12Myuemu, from Corning Inc. and Millipore, polyethyleneterephthalate off tallates made, polycarbonate, since collagen treated poly Tet data fluoroethylene made of film is commercially available, purchased them Can be used. An example of the measurement method using these is shown below.
<表皮角化細胞層膜を介しての物質の移動の抑制による皮膚バリア機能の測定>
凍結正常ヒト表皮角化細胞(NHEK)(倉敷紡績株式会社製)を解凍し、0.15mM−Ca含有培養液(Humedia−KG2;倉敷紡績株式会社製)にて、37℃、50%二酸化炭素雰囲気下で培養した。この正常ヒト表皮角化細胞(NHEK)をMillicell Tissue Culture Plate(ミリポア社製)にコーニング社製トランスウェル(直径12mm、ポリエチレンテレフタレート0.4μmポア)をセットし、上層0.5ml、下層0.5mlの前記培養液を入れ、2×10 5 /cm 2 で播種し、さらに72時間培養した。
コンフルエントになったことを確認し、1.45mM−Ca含有−Humedia−KG2培地に交換し、その後96時間培養した。その後、被検試料である抽出物を含有する培養液に交換して、培養を継続し、1日後、2日後、3日後にTER(Transepithelial Electrical Resistance)値(Ωm 2 )を測定する。被検試料含有培養液の添加時のTER値に対する、一定時間後のTER値を測定することによって、前記阻害濃度が決定される。
この様な阻害濃度は簡易的にヘスペリジンの含有量によって推定できる。これはトウヒ中に含まれる皮膚バリア機能を向上させる作用を有する成分がヘスペリジンと類似した溶出挙動を示すためである。前記の皮膚外用剤への配合において十分に皮膚バリア機能を向上しうる抽出物又は分画精製物としては、ヘスペリジンの含有量が0.05〜0.1質量%のものが好ましく例示できる。かかる抽出物又は分画精製物を、0.01〜1質量%、好ましくは0.05〜0.5質量%含有せしめることにより、皮膚バリア機能を向上せしめる皮膚外用剤とすることができる。
<Measurement of skin barrier function by inhibiting movement of substance through epidermal keratinocyte layer membrane>
Frozen normal human epidermal keratinocytes (NHEK) (manufactured by Kurashiki Boseki Co., Ltd.) are thawed and cultured at 37 ° C. and 50% carbon dioxide in a 0.15 mM-Ca-containing culture solution (Humdia-KG2; Kurashiki Boseki Co., Ltd.). Cultured under atmosphere. The normal human epidermal keratinocytes (NHEK) were set on a Millicell Tissue Culture Plate (Millipore) and Corning Transwell (diameter 12 mm, polyethylene terephthalate 0.4 μm pore), upper layer 0.5 ml, lower layer 0.5 ml. Of the above culture solution was added, seeded at 2 × 10 5 / cm 2 , and further cultured for 72 hours.
After confirming that the cells were confluent, the medium was replaced with 1.45 mM-Ca-containing-Humdia-KG2 medium, and then cultured for 96 hours. Then exchanged with a culture medium containing extract is a test sample, the culture was continued, after one day, after two days, measured TER (Transepithe l ial Electrical Resistance) values (Omega m 2) after 3 days . The inhibitory concentration is determined by measuring the TER value after a certain time with respect to the TER value at the time of adding the test sample-containing culture solution.
Such an inhibitory concentration can be easily estimated by the content of hesperidin. This is because a component having an action of improving the skin barrier function contained in spruce shows an elution behavior similar to that of hesperidin. Preferred examples of the extract or fraction purified product that can sufficiently improve the skin barrier function in the above-mentioned external preparation for skin include those having a hesperidin content of 0.05 to 0.1% by mass. By containing 0.01 to 1% by mass, preferably 0.05 to 0.5% by mass of the extract or the fraction-purified product , a skin external preparation that improves the skin barrier function can be obtained.
前記測定において、10%以上の抵抗値の増加が認められる場合に、本発明の皮膚外用剤に含有させるのに適切な抽出物又は分画精製物の濃度であると判断した。この時、被検試料の力価が一定になるように抽出物又は分画精製物を水、50%エタノール水溶液、50%1,3−ブタンジオールなどで希釈して配合することもできる。
In the measurement, when an increase in resistance value of 10% or more was observed, it was determined that the concentration of the extract or fraction purified product was appropriate for inclusion in the external preparation for skin of the present invention. At this time, the extract or fraction- purified product can be diluted with water, 50% ethanol aqueous solution, 50% 1,3-butanediol or the like so that the titer of the test sample becomes constant.
本発明の皮膚外用剤に於いては、前記のミカン科ミカン属ダイダイの果皮(トウヒ)の抽出物又は分画精製物以外に、通常化粧料や皮膚外用医薬で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プ
ロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブタンジオール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸,ローカストビーンガム,サクシノグルカン,カロニン酸,キチン,キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤、表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類、表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類、レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類、ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類、エタノール、イソプロパノール等の低級アルコール類、ビタミンA又はその誘導体、ビタミンB 6 塩酸塩,ビタミンB 6 トリパルミテート,ビタミンB 6 ジオクタノエート,ビタミンB 2 又はその誘導体,ビタミンB 12 ,ビタミンB 15 又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類、フェノキシエタノール等の抗菌剤などが好ましく例示できる。これらを常法に従って処理することにより、本発明の皮膚外用剤は製造することが出来る。
The external preparation for skin of the present invention contains optional components usually used in cosmetics and external preparations for skin, in addition to the above-mentioned extract of the citrus mandarin genus perilla (spruce) or purified fraction. I can do it. Examples of such optional ingredients include macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, and hardened coconut oil. Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax, higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl Alcohol, behenyl alcohol, octyldodecanol, higher alcohol such as myristyl alcohol, cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate, dimethylpolysiloxane, methylphenylpoly Loxane, linear polysiloxane such as diphenylpolysiloxane, cyclic polysiloxane such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oil such as modified polysiloxane such as fluorine-modified polysiloxane, anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfate, chloride Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide, imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine, sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid esters and alkyl glucosides, polyethylene glycol, glycerin, 1,3-butanediol, erythritol, sorbitol, xylitol, maltitol, propylene glycol Polyol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, 1,2-octanediol and other polyhydric alcohols, pyrrolidone carvone Moisturizing ingredients such as sodium acid, lactic acid, sodium lactate, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin Sulfuric acid, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydro Xiethyl guar gum, carboxymethyl guar gum, dextran, keratosulfuric acid, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, sodium polyacrylate, polyethylene Thickeners such as glycol and bentonite, surface may be treated, powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silica), aluminum oxide, barium sulfate Surface may be treated, bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide inorganic pigments, surface may be treated, titanium mica, fish Phosphorous foil, bismuth oxychloride, etc. Red, No. 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201 No., Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, and the like, polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer Organic powders such as paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- ( UV absorption such as 2'-hydroxy-5'-t-octylphenyl) benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane Agents, ethanol, lower alcohols such as isopropanol, vitamin A or its derivatives, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or derivatives thereof, vitamin B 12, vitamin B 15 Or vitamin B such as derivatives thereof, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, vitamins such as pyrroloquinoline quinone, Preferred examples include antibacterial agents such as phenoxyethanol. The skin external preparation of this invention can be manufactured by processing these according to a conventional method.
本発明の皮膚外用剤は、前記本発明の製造方法に従って製造されたものであり、前記ミカン科ミカン属ダイダイの果皮(トウヒ)の抽出物又は分画精製物を、表皮角化細胞層膜の透過性を10%以上抑制するに足る量、好適にはヘスペリジンの含有量が0.05〜0.1質量%のものを0.01〜1質量%含有することを特徴としている。この様な透過性の抑制効果について、効果を確認した後に配合されるので、ロット毎の力価の変動が無く、生化学的に安定した皮膚外用剤とすることができる。通常、生薬等の植物体などの抽出物を含有する皮膚外用剤において、有効成分の含有量が生薬等の産地や季節により異なるため、生理化学的効果が大きく異なってしまう場合があったが、本発明の皮膚外用剤では生理学的効果は、生薬等の抽出物を含有する形態においても安定している。
The external preparation for skin of the present invention, the has been produced according to the production method of the present invention, the extract or fraction purified product pericarp (spruce) of the Rutaceae Citrus aurantium, the epidermal keratinocytes layer film An amount sufficient to suppress the permeability by 10% or more , preferably 0.01 to 1% by mass with a hesperidin content of 0.05 to 0.1% by mass . About such an inhibitory effect of permeability, since it is blended after confirming the effect, there is no fluctuation of the titer from lot to lot, and a biochemically stable skin external preparation can be obtained. Usually, in skin external preparations containing extracts such as herbal medicines, etc., because the content of active ingredients varies depending on the production area and season of herbal medicines, etc., the physiochemical effects may vary greatly, In the external preparation for skin of the present invention, the physiological effect is stable even in a form containing an extract such as a herbal medicine.
電流の抵抗値による皮膚バリア機能の測定
凍結正常ヒト表皮角化細胞(NHEK)(倉敷紡績株式会社製)を解凍し、0.15mM−Ca含有培養液(Humedia−KG2;倉敷紡績株式会社製)にて、37℃、50%二酸化炭素雰囲気下で培養した。この正常ヒト表皮角化細胞(NHEK)をMillicell Tissue Culture Plate(ミリポア社製)にコーニング社製トランスウェル(直径12mm、ポリエチレンテレフタレート0.4μmポア)をセットし、上層0.5ml、下層0.5mlの前記培養液を入れ、2×10 5 /cm 2 で播種し、さらに72時間培養した。コンフルエントになったことを確認し、1.45mM−Ca含有−Humedia−KG2培地に交換し、その後96時間培養した。その後、実施例1のトウヒ抽出物を10-5v/v%となるように培養液中に添加した培養液に交換して、培養を継続し、1日後、2日後、3日後にTERを測定した。抽出物の添加時のTER(Transepithelial Electrical Resistance)値(Ωm 2 )に対する、一定時間後のTER値の割合(%)で示した。結果を図1に示す。さらに、前記実施例1において、作製したヘスペリジン含有量の低い比較品1に関しても同様の測定を実施した。結果を図2に示す。
Measurement of skin barrier function by resistance of electric current Frozen normal human epidermal keratinocytes (NHEK) (manufactured by Kurashiki Boseki Co., Ltd.) are thawed, and 0.15 mM-Ca-containing culture solution (Humdia-KG2; Kurashiki Boseki Co., Ltd.) And cultured at 37 ° C. in a 50% carbon dioxide atmosphere. The normal human epidermal keratinocytes (NHEK) were set on a Millicell Tissue Culture Plate (Millipore) and Corning Transwell (diameter 12 mm, polyethylene terephthalate 0.4 μm pore), upper layer 0.5 ml, lower layer 0.5 ml. Of the above culture solution was added, seeded at 2 × 10 5 / cm 2 , and further cultured for 72 hours. After confirming that the cells were confluent, the medium was replaced with 1.45 mM-Ca-containing-Humdia-KG2 medium, and then cultured for 96 hours. Thereafter, the spruce extract of Example 1 was replaced with a culture solution added to the culture solution so as to be 10 −5 v / v%, and the culture was continued. After 1 day, 2 days, and 3 days, TER was changed. It was measured. For extract upon addition TER (Transepithe l ial Electrical Resistance) values (Omega m 2), it is a percentage of the TER value after a predetermined time (%). The results are shown in FIG. Furthermore, in the said Example 1, the same measurement was implemented also about the manufactured comparative product 1 with low hesperidin content. The results are shown in FIG.
下記に示す処方に従って、本発明の皮膚外用剤である乳液を作製した。即ち、(A)の各成分を混合し、80℃に加熱した。一方、(B)の各成分を80℃に加熱した。(A)の混合物に(B)の混合物を加えて撹拌して乳化させ、更に(C)を加えて中和し、その後35℃にまで撹拌、冷却し、実施例3の乳液を作製した。実施例3の乳液において、実施例1のトウヒ抽出物を水に置換した比較例1も作製した。
According to the prescription shown below, the emulsion which is a skin external preparation of this invention was produced. That is, the components (A) were mixed and heated to 80 ° C. On the other hand, each component of (B) was heated to 80 degreeC. The mixture of (B) was added to the mixture of (A) and stirred to emulsify, and further (C) was added to neutralize, and then the mixture was stirred and cooled to 35 ° C. to prepare the emulsion of Example 3 . Comparative Example 1 was also produced in which the spruce extract of Example 1 was replaced with water in the emulsion of Example 3 .
(試験例1)
健常な成人男子5名の上腕内側部に1cm×1cmの3部位を設定し、未処置部位のTEWL値を測定した。次いで、サージカルテープ(3M社製)により、浸潤液が出るまでテープストリッピングを繰り返し、テープストリッピング直後のTEWL値を測定した。TEWL値の測定後、1部位には実施例3のトウヒ抽出物含有乳液、もう一部位には比較例1を塗布し、残りの1部位は何も塗布しないで放置した。このサンプル塗布を1日3回行い、サンプル塗布48時間後に再度TEWL値を測定し、テープストリッピング直後からのTEWLの回復状況を評価した。結果を、図3に示す。
(Test Example 1)
Three sites of 1 cm × 1 cm were set on the inner side of the upper arm of five healthy adult males, and the TEWL value of the untreated site was measured. Next, tape stripping was repeated with a surgical tape (manufactured by 3M) until the infiltrating solution was produced, and the TEWL value immediately after the tape stripping was measured. After measuring the TEWL value, the spruce extract-containing emulsion of Example 3 was applied to one site, and Comparative Example 1 was applied to the other part, and the remaining 1 site was left uncoated. This sample application was performed three times a day, and the TEWL value was measured again 48 hours after the sample application, and the recovery state of TEWL immediately after tape stripping was evaluated. The results are shown in FIG.
図3の結果より、テープストリッピング後に、何も塗布しない未処置に対して、比較例1を塗布した部位では、若干の回復の促進が認められたが、トウヒ抽出物を含有した実施例3の乳液においては、損傷されたバリア機能の回復の顕著な促進が認められ、本発明のスクリーニング方法で、バリア能の向上効果の認められたトウヒ抽出物に関して、ヒトの皮膚においても皮膚バリア能の回復効果が認められた。
From the results shown in FIG. 3, in the region where Comparative Example 1 was applied to the non-treated area where nothing was applied after tape stripping, a slight promotion of recovery was observed, but Example 3 containing a spruce extract was observed. In the emulsion, significant improvement in the recovery of damaged barrier function was observed, and the recovery of the skin barrier ability was also observed in human skin with respect to the spruce extract in which the effect of improving the barrier ability was recognized by the screening method of the present invention. The effect was recognized.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005375332A JP2007176835A (en) | 2005-12-27 | 2005-12-27 | External preparation for skin, for improving skin barrier function and its production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005375332A JP2007176835A (en) | 2005-12-27 | 2005-12-27 | External preparation for skin, for improving skin barrier function and its production method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007176835A JP2007176835A (en) | 2007-07-12 |
JP2007176835A5 true JP2007176835A5 (en) | 2009-01-15 |
Family
ID=38302361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005375332A Pending JP2007176835A (en) | 2005-12-27 | 2005-12-27 | External preparation for skin, for improving skin barrier function and its production method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007176835A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008007411A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Transglutaminase production promoter and epidermal keratinization-normalizing agent |
JP2008007412A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Involucrin production promoter and epidermal keratinization-normalizing agent |
JP5275711B2 (en) * | 2008-07-23 | 2013-08-28 | 日本メナード化粧品株式会社 | Keratinocytes differentiated from stem cells and artificial epidermal sheets |
JP2014091727A (en) * | 2012-11-06 | 2014-05-19 | Fancl Corp | Mif secretion inhibitor |
JP2020164486A (en) | 2019-03-29 | 2020-10-08 | 丸善製薬株式会社 | Anti-aging agents, antioxidants, anti-inflammatory agents, and whitening agents, as well as cosmetics |
JP7285504B2 (en) * | 2021-10-14 | 2023-06-02 | 国立大学法人東海国立大学機構 | Scalp condition improving agent and cosmetic containing the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08208451A (en) * | 1995-02-03 | 1996-08-13 | Kao Corp | Skin-beautifying agent mixed with extract of crude medicine from plant |
JP4717340B2 (en) * | 1998-03-31 | 2011-07-06 | 株式会社 資生堂 | Laminin 5 production promoter |
JP4214434B2 (en) * | 1998-11-12 | 2009-01-28 | 東洋紡績株式会社 | Cultured skin, production method and use thereof |
JP2000212028A (en) * | 1999-01-27 | 2000-08-02 | Pola Chem Ind Inc | Preparation for external use for skin for treatment of stress disorder |
JP2001131049A (en) * | 1999-11-04 | 2001-05-15 | Lion Corp | Skin preparation for external use |
JP3953847B2 (en) * | 2002-03-11 | 2007-08-08 | 花王株式会社 | Lipolysis accelerator |
JP2004000051A (en) * | 2002-05-31 | 2004-01-08 | Ecodevice Co Ltd | Cell culture vessel and method for manufacturing cultured cell |
JP4787461B2 (en) * | 2003-05-15 | 2011-10-05 | 花王株式会社 | Skin cosmetics |
JP2005082561A (en) * | 2003-09-10 | 2005-03-31 | B Road:Kk | Cosmetic |
JP2005137307A (en) * | 2003-11-07 | 2005-06-02 | Japan Science & Technology Agency | Method for evaluating damage to cell and tissue and apparatus for measuring the same damage |
-
2005
- 2005-12-27 JP JP2005375332A patent/JP2007176835A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5284345B2 (en) | Wrinkle suppression method | |
CN114983840B (en) | Skin barrier repair composition capable of resisting external stimulus | |
JP2007176835A5 (en) | ||
JP2010511376A (en) | Method for distinguishing skin barrier function, screening method for material for enhancing skin barrier function using the same, material for enhancing skin barrier function, and cosmetic comprising the material for enhancing skin barrier function | |
JP5707062B2 (en) | Skin external composition | |
JP2007176835A (en) | External preparation for skin, for improving skin barrier function and its production method | |
JP2008019230A5 (en) | ||
JP2010013373A (en) | Cosmetic suitable for strengthening horny layer cell | |
JP2003267817A (en) | Skin distributing and permeating composition and skin care preparation and cosmetic formulated with the composition | |
JP5209848B2 (en) | Topical skin preparation | |
JP5198732B2 (en) | Melanin production inhibitor | |
JP2007176830A (en) | External preparation for skin, for improving skin barrier function and its production method | |
JP2007176830A5 (en) | ||
JP2006298868A (en) | External preparation for skin, suitable for cleansing cosmetic | |
JP4471722B2 (en) | Skin preparation for summer | |
JP2007186442A5 (en) | ||
JP2010150179A (en) | Cosmetic for skin moisturization | |
JP2006036716A5 (en) | ||
JP4616590B2 (en) | Skin external preparation having anti-inflammatory action | |
JP2005306816A (en) | Skin care external preparation for summer | |
JP4404352B2 (en) | Skin preparation for summer | |
JP2006219450A (en) | Skin care preparation | |
JP4663265B2 (en) | External preparation for skin having skin roughening action | |
JP5688237B2 (en) | Topical skin preparation | |
JP2013173697A5 (en) |